Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
New IRS data summarized by the Kiplinger Letter shows the ultra-wealthy paid a 23.61% effective federal tax rate in 2...
A single insider purchase can spark questions about a stock, but it isn’t a sure shot signal. This article digs into ...
Bandwidth Inc. released a mixed Q4 2025 report that sheds light on customer growth, margins, and the path to profitab...
A deep dive into Ted Turner’s debt-fueled rise explains why leveraging growth can backfire. Today’s investors should ...
Dave & Buster's is blending food, drinks, and arcade play into a growing business model. This analysis breaks down th...
A sudden dividend cut or pause can shake confidence and cash flow. This guide explains what to do when there goes div...
A prominent money advisor challenges the traditional retirement bucket approach, proposing a simple one-year cash cus...
A widely cited estimate of Genghis Khan's wealth—genghis khan worth $120—sparks a timely discussion on how historians...
When a smart-home name rallies, traders pay attention. This piece breaks down why resideo technologies stock popped o...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
Meta Platforms is pouring billions into AI infrastructure. This piece breaks down why that spending could pay off for...